KROS earnings: a positive outcome, +27.7%

On November 4, 2021, Keros Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +27.7% in the window around the event. It had already run +7.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.